Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.
van der Aa MN, van Leenders GJ, Steyerberg EW, van Rhijn BW, Jöbsis AC, Zwarthoff EC, van der Kwast TH. van der Aa MN, et al. Among authors: van rhijn bw, van leenders gj, van der kwast th. Hum Pathol. 2005 Sep;36(9):981-6. doi: 10.1016/j.humpath.2005.06.017. Hum Pathol. 2005. PMID: 16153461
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
Postma R, Schröder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH. Postma R, et al. Among authors: van leenders gj, van der kwast th. Eur Urol. 2007 Jul;52(1):89-97. doi: 10.1016/j.eururo.2007.01.030. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17257742 Clinical Trial.
Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?
Wolters T, Roobol MJ, Schröder FH, van der Kwast TH, Roemeling S, van der Cruijsen-Koeter IW, Bangma CH, van Leenders GJ; ERSPC Rotterdam section. Wolters T, et al. Among authors: van leenders gj, van der cruijsen koeter iw, van der kwast th. BJU Int. 2008 Feb;101(3):283-8. doi: 10.1111/j.1464-410X.2007.07267.x. Epub 2007 Oct 8. BJU Int. 2008. PMID: 17922858 Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer.
Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schröder FH, van der Kwast TH. Wolters T, et al. Among authors: van den bergh rc, van leenders gj, van leeuwen pj, van der kwast th. Eur Urol. 2010 May;57(5):821-9. doi: 10.1016/j.eururo.2009.07.027. Epub 2009 Jul 29. Eur Urol. 2010. PMID: 19664875
Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
Van der Kwast TH, Evans A, Lockwood G, Tkachuk D, Bostwick DG, Epstein JI, Humphrey PA, Montironi R, Van Leenders GJ, Pihl CG, Neetens I, Kujala PM, Laurila M, Mazerolles C, Bubendorf L, Finelli A, Watson K, Srigley J. Van der Kwast TH, et al. Among authors: van leenders gj. Am J Surg Pathol. 2010 Feb;34(2):169-77. doi: 10.1097/PAS.0b013e3181c7997b. Am J Surg Pathol. 2010. PMID: 20061936
No evidence of FGFR3 mutations in prostate cancer.
Zuiverloon TC, Boormans JL, Trapman J, van Leenders GJ, Zwarthoff EC. Zuiverloon TC, et al. Among authors: van leenders gj. Prostate. 2011 May;71(6):637-41. doi: 10.1002/pros.21279. Epub 2010 Oct 18. Prostate. 2011. PMID: 20957671
242 results